About Us
The Global Coalition of TB Advocates (GCTA) is a global platform that bridges the gap between civil society organizations and other stakeholders in the tuberculosis (TB) response, including the World Health Organization, the Global Fund to Fight AIDS, Tuberculosis and Malaria, Unitaid, and other global health agencies, ensuring that communities are involved in all TB processes. Its primary mission is to ensure that the communities affected by TB are at the center of all advocacy efforts, and to champion issues identified as a priority by communities affected by TB. Since its inception in March 2013, GCTA has contributed to the global TB agenda through, inter alia, activism for the price reduction of TB technologies, including GeneXpert cartridges, the TB drugs bedaquiline and delamanid; capacity building of TB communities; data collection on community perspectives on the impact of COVID-19 on the TB epidemic; and the publication of a report with 20 recommendations towards activating a human rights response to TB.
Vision
A world free of Tuberculosis
Mission
To ensure accountability in global TB goals through coalition building, community-led monitoring, advocacy and capacity building
Strategic Objectives (2021-2025)
GCTA’s Strategy for 2021-2025 is firmly grounded in its incorporating documents, i.e. to ensure a world free of tuberculosis: zero TB deaths, zero TB disease and zero TB suffering, and led by its overall mission of ensuring the voices of TB affected communities influence the global TB and health agenda. As time progressed through the past strategy, it became evident that GCTA’s voice permeated numerous levels of global decision-making on TB.
Strategic Objective 1: Issue-Based Advocacy
GCTA represents community voices by raising issues that are important to TB communities at the global stage, such as TPT, access to all-oral regimens, community-led monitoring and accountability, rights-based TB responses, and health systems strengthening for TB, and ensuring global discourse on these issues reach TB communities regionally and locally.
Strategic Objective 2: Coalition-Building and Strategic Communications
GCTA’s effectiveness is informed through the strength of its members, i.e., regional and country partners. GCTA pledges to institutionalize periodic sharing sessions with regional and country partners to ensure that all advocacy is informed by relevant local and regional data. GCTA also pledges to improve strategic communications on matters important to TB communities.
Strategic Objective 3: Improving Governance, Accountability, and Representation
Governance issues can be an impediment to effective and impactful representation of TB communities. GCTA will undertake a number of strengthening exercises to eliminate these barriers, including via the strengthening of regional focal points and increasing accountability within.
Strategic Objective 4: Capacity Building
Capacity building of TB communities remains very much necessary – and arguably GCTAs strategic advantage. GCTA understands, however, that this capacity building must progress with concrete aims in mind and with predetermined foci. As such, GCTA will focus on capacity building in these areas: TB literacy, relevance and application of updated guidelines, and translating domestic and regional results to global advocacy and vice versa.
Read the GCTA Strategic Plan 2021-2025 here
Our Team
Our Partners
Shortage of medicines used for treating drug-sensitive and drug-resistant TB began last year and has been continuing across India for about a year now. It started with shortage of Rifampicin and now includes drug-resistant TB drugs too
Press Release: Global Fund Announces New Mechanism to Increase Access to More Effective Mosquito Nets to Prevent Malaria
Using innovative financing, @GlobalFund is making health products more affordable & accessible for low-resourced communities.
